ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,620Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 807

$447K Total Retail Price of All Prescriptions

Rank: 165 out of 807

243 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 243 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

39% of this provider’s 243 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

0% of this provider’s 7,869 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 886 649 1 1
LISINOPRIL 638 468 2 2
METFORMIN HCL 511 381 3 12
PROAIR HFA 477 377 4 43
ASPIRIN EC 345 337 5 130
AMOX TR-POTASSIUM CLAVULANATE 270 183 6 140
ACETAMINOPHEN-CODEINE 262 173 S3 7 93
LOSARTAN POTASSIUM 257 197 8 14
RANITIDINE HCL 248 163 9 34
OMEPRAZOLE 235 170 10 4
ALENDRONATE SODIUM 207 185 11 20
NITROSTAT 188 147 12 104
LEVOTHYROXINE SODIUM 166 101 13 3
METOPROLOL SUCCINATE 159 110 14 13
SYMBICORT 157 140 15 116
LANSOPRAZOLE 152 139 16 103
LANTUS SOLOSTAR 138 99 17 42
ATENOLOL 130 84 18 7
ALLOPURINOL 124 69 19 26
OYSTER SHELL CALCIUM W-VIT D 119 119 20 201
ADVAIR DISKUS 114 77 21 33
AMLODIPINE BESYLATE 110 81 22 5
ZETIA 103 62 23 59
TAMSULOSIN HCL 99 79 24 27
METOPROLOL TARTRATE 94 55 25 8
LOSARTAN-HYDROCHLOROTHIAZIDE 91 82 26 55
NOVOLOG FLEXPEN 89 73 27 75
AZITHROMYCIN 87 59 28 57
NEXIUM 85 23 29 68
ULTICARE 83 60 30 233
ISOSORBIDE MONONITRATE ER 81 62 31 36
SINGLE USE SWAB 78 52 32 234
PREDNISOLONE 78 61 32 280
LIDODERM 76 63 34 96
FUROSEMIDE 74 70 35 6
SURE COMFORT ALCOHOL 72 52 36 208
IBUPROFEN 71 41 37 97
LORATADINE 69 59 38 207
ALCOHOL PREP SWABS 67 47 10 39 293
CLOPIDOGREL 66 51 40 47
NOVOLOG MIX 70-30 FLEXPEN 63 38 41 202
CLOTRIMAZOLE-BETAMETHASONE 63 47 41 198
CHERATUSSIN AC 62 62 43 300
FLUTICASONE PROPIONATE 61 33 44 30
ALCOHOL PREP PADS 59 46 45 306
HYDRALAZINE HCL 55 32 46 62
PLAVIX 55 37 46 60
QVAR 52 47 48 258
DULERA 51 43 49 239
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.